Name | Number of supported studies | Average coverage | |
---|---|---|---|
microglial cell | 4 studies | 21% ± 4% |
Insufficient scRNA-seq data for expression of TLR6 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 582.20 | 577 / 578 | 90% | 3.81 | 1038 / 1155 |
breast | 91% | 210.31 | 417 / 459 | 89% | 4.14 | 998 / 1118 |
skin | 93% | 156.46 | 1675 / 1809 | 82% | 4.32 | 387 / 472 |
esophagus | 82% | 122.90 | 1179 / 1445 | 76% | 3.42 | 139 / 183 |
uterus | 85% | 109.52 | 144 / 170 | 64% | 1.82 | 293 / 459 |
ovary | 91% | 135.62 | 163 / 180 | 47% | 1.05 | 202 / 430 |
intestine | 94% | 370.36 | 910 / 966 | 39% | 1.00 | 205 / 527 |
bladder | 86% | 161.43 | 18 / 21 | 46% | 1.53 | 230 / 504 |
adrenal gland | 100% | 318.22 | 257 / 258 | 30% | 0.85 | 70 / 230 |
brain | 50% | 80.75 | 1320 / 2642 | 77% | 2.50 | 543 / 705 |
kidney | 55% | 99.47 | 49 / 89 | 65% | 1.84 | 583 / 901 |
pancreas | 35% | 43.45 | 114 / 328 | 84% | 2.72 | 150 / 178 |
liver | 89% | 114.58 | 201 / 226 | 26% | 0.68 | 106 / 406 |
stomach | 62% | 81.92 | 223 / 359 | 50% | 1.32 | 143 / 286 |
prostate | 91% | 167.94 | 222 / 245 | 20% | 0.34 | 100 / 502 |
thymus | 74% | 138.18 | 483 / 653 | 34% | 0.77 | 207 / 605 |
lymph node | 0% | 0 | 0 / 0 | 100% | 7.49 | 29 / 29 |
spleen | 100% | 2181.34 | 241 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 100% | 3465.68 | 928 / 929 | 0% | 0 | 0 / 0 |
adipose | 98% | 299.00 | 1180 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 82% | 4.98 | 37 / 45 |
blood vessel | 73% | 133.95 | 977 / 1335 | 0% | 0 | 0 / 0 |
heart | 61% | 80.18 | 529 / 861 | 0% | 0 | 0 / 0 |
muscle | 15% | 12.89 | 117 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 10% | 0.20 | 8 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0035666 | Biological process | TRIF-dependent toll-like receptor signaling pathway |
GO_0002755 | Biological process | MyD88-dependent toll-like receptor signaling pathway |
GO_0043507 | Biological process | positive regulation of JUN kinase activity |
GO_0002224 | Biological process | toll-like receptor signaling pathway |
GO_2001238 | Biological process | positive regulation of extrinsic apoptotic signaling pathway |
GO_0006954 | Biological process | inflammatory response |
GO_0001774 | Biological process | microglial cell activation |
GO_0034136 | Biological process | negative regulation of toll-like receptor 2 signaling pathway |
GO_0038124 | Biological process | toll-like receptor TLR6:TLR2 signaling pathway |
GO_0071726 | Biological process | cellular response to diacyl bacterial lipopeptide |
GO_0045087 | Biological process | innate immune response |
GO_0007165 | Biological process | signal transduction |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_1903428 | Biological process | positive regulation of reactive oxygen species biosynthetic process |
GO_1900017 | Biological process | positive regulation of cytokine production involved in inflammatory response |
GO_0043032 | Biological process | positive regulation of macrophage activation |
GO_0032731 | Biological process | positive regulation of interleukin-1 beta production |
GO_0006955 | Biological process | immune response |
GO_1900227 | Biological process | positive regulation of NLRP3 inflammasome complex assembly |
GO_0043123 | Biological process | positive regulation of canonical NF-kappaB signal transduction |
GO_0042496 | Biological process | detection of diacyl bacterial lipopeptide |
GO_0045429 | Biological process | positive regulation of nitric oxide biosynthetic process |
GO_0032717 | Biological process | negative regulation of interleukin-8 production |
GO_0042742 | Biological process | defense response to bacterium |
GO_0007250 | Biological process | activation of NF-kappaB-inducing kinase activity |
GO_0046209 | Biological process | nitric oxide metabolic process |
GO_1904646 | Biological process | cellular response to amyloid-beta |
GO_0140052 | Biological process | cellular response to oxidised low-density lipoprotein particle stimulus |
GO_0032755 | Biological process | positive regulation of interleukin-6 production |
GO_0043235 | Cellular component | receptor complex |
GO_0005886 | Cellular component | plasma membrane |
GO_0045121 | Cellular component | membrane raft |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0030670 | Cellular component | phagocytic vesicle membrane |
GO_0035355 | Cellular component | Toll-like receptor 2-Toll-like receptor 6 protein complex |
GO_0038023 | Molecular function | signaling receptor activity |
GO_0004888 | Molecular function | transmembrane signaling receptor activity |
GO_0001540 | Molecular function | amyloid-beta binding |
GO_0005102 | Molecular function | signaling receptor binding |
GO_0035663 | Molecular function | Toll-like receptor 2 binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0071723 | Molecular function | lipopeptide binding |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0005515 | Molecular function | protein binding |
GO_0061809 | Molecular function | NAD+ nucleotidase, cyclic ADP-ribose generating |
Gene name | TLR6 |
Protein name | Toll-like receptor 6 (CD antigen CD286) Toll-like receptor 6 Toll-like receptor |
Synonyms | |
Description | FUNCTION: Participates in the innate immune response to Gram-positive bacteria and fungi. Specifically recognizes diacylated and, to a lesser extent, triacylated lipopeptides . In response to diacylated lipopeptides, forms the activation cluster TLR2:TLR6:CD14:CD36, this cluster triggers signaling from the cell surface and subsequently is targeted to the Golgi in a lipid-raft dependent pathway . Acts via MYD88 and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response. Recognizes mycoplasmal macrophage-activating lipopeptide-2kD (MALP-2), soluble tuberculosis factor (STF), phenol-soluble modulin (PSM) and B.burgdorferi outer surface protein A lipoprotein (OspA-L) cooperatively with TLR2 . In complex with TLR4, promotes sterile inflammation in monocytes/macrophages in response to oxidized low-density lipoprotein (oxLDL) or amyloid-beta 42. In this context, the initial signal is provided by oxLDL- or amyloid-beta 42-binding to CD36. This event induces the formation of a heterodimer of TLR4 and TLR6, which is rapidly internalized and triggers inflammatory response, leading to the NF-kappa-B-dependent production of CXCL1, CXCL2 and CCL9 cytokines, via MYD88 signaling pathway, and CCL5 cytokine, via TICAM1 signaling pathway, as well as IL1B secretion . . |
Accessions | D1CS99 B6RFS7 Q9Y2C9 D1CS91 D1CS97 D6RAV7 ENST00000508254.5 B6CH44 D1CS98 B6CH42 ENST00000381950.2 [Q9Y2C9-1] B6CH37 D1CS96 D1CS93 D1CS92 D1CSA0 ENST00000508254.6 [Q9Y2C9-1] B6CH45 |